Stephanie Forschner-Dancause, Ph.D

  • Associate Teaching Professor, Director of the BSPS Programs, Director of the Certificate Program in Cannabis Studies
  • Office: 395N
  • Phone: 401.874.5517
  • Email:
  • Office Location: Avedisian Hall, 7 Greenhouse Road, Kingston, RI 02881


Dr. Forschner-Dancause received her Ph.D in pharmaceutical sciences from the University of Rhode Island in 2012 and has extensive experience in microbial ecology and natural product chemistry.  Her scientific interests focus on the discovery of microbial natural products with biological activities capable of modulating human health and environmental interactions.  Dr. Forschner-Dancause currently teaches courses in pharmacology and pharmaceutical research with an emphasis on active learning and authentic assessments to prepare students to meet the real-world challenges in pharmaceutical research and development.        


Postdoctoral Fellowship, Salve Regina University
Ph.D., Pharmaceutical Sciences, The University of Rhode Island
B.S., Marine Biology, minor in Chemistry, The University of Rhode Island

Selected Publications

Meschwitz SM, Teasdale ME, Mozzer A, Martin N, Liu J, Forschner-Dancause S, and Rowley DC. (2019) Antagonism of Quorum Sensing Phenotypes by Analogs of the Marine Bacterial Secondary Metabolite 3-methyl-N-(2’-phenylethyl)-butyramide. Mar Drugs. 17: 389.

Forschner-Dancause S, Poulin E, and Meschwitz S. (2016) Quorum sensing inhibition and structure activity relationships of β-keto esters. Molecules 21: 971. 

Prieto-Davó A, Villarreal-Gómez L, Forschner-Dancause S, Rowley D, Stach J, Bull A, Smith D, and Jensen P. (2013) Targeted search for actinomycetes from near-shore and deep-sea marine sediments.  FEMS Microbiol. Ecol. 84: 510-8.

Graff JR, Forschner-Dancause S, Menden-Deuer S, Long R, and Rowley D. (2013) Vibrio cholerae exploits sub-lethal concentrations of a competitor-produced antibiotic to avoid toxic interactions. Front Microbio 4:8. DOI: 10.3389/fmicb.2013.00008

Forschner-Dancause S, LaPlant K, Smith DC, and Rowley DC. (2012) Going deep for drug discovery: an ocean to bedside approach to explore sub-seafloor microbes for the next generation of antibiotics.  Med Health R I 95: 292-3.

Teasdale ME, Donovan KA, Forschner-Dancause SR, and Rowley DC. (2011) Gram-positive marine bacteria as a potential resource for the discovery of quorum sensing inhibitors. Mar Biotechnol (NY) 13: 722-732.

Forschner SR, Sheffer R, Rowley DC, and Smith DC. (2009) Microbial diversity in Cenozoic sediments recovered from the Lomonosov Ridge in the Central Arctic basin. Environ Microbiol 11: 630-639.